2020年度妇科恶性肿瘤最新研究进展及展望  

Leading research progress and prospect of gynecological oncology in 2020

作　　者：朱俊 吴小华 ZHU Jun;WU Xiaohua(Department of Gynecologic Oncology,Fudan University Shanghai Cancer Center,Department of Oncology,Shanghai Medical College,Fudan University,Shanghai 200032,China)

机构地区：[1]复旦大学附属肿瘤医院妇瘤科,复旦大学上海医学院肿瘤学系,上海200032

出　　处：《中国癌症杂志》2021年第4期250-256,共7页China Oncology

摘　　要：妇科肿瘤领域在过去1年取得了诸多重磅性研究成果,三大常见妇科恶性肿瘤,包括宫颈癌、子宫体癌和卵巢癌,在手术治疗、辅助治疗及靶向治疗方面均有突破性进展。靶向治疗的应用使卵巢癌患者的生存状况得到了极大程度的改善,对于特定人群的卵巢癌患者,靶向治疗带来了显著的生存获益。在手术治疗方面,宫颈癌根治性手术在传统开腹手术与腹腔镜手术之间的安全性比较有了更多研究数据;子宫内膜癌早期手术治疗模式也在不断更新。There have been many leading research achievements in the past year in the field of gynecologic oncology.Breakthroughs in surgical treatment,adjuvant therapy and targeted therapy have been made in the common gynecological malignancies,including cervical cancer,uterine cancer and ovarian cancer.Targeted therapy has greatly improved the prognosis of patients with ovarian cancer.For a specific kind of ovarian cancer patients,targeted therapy has resulted in significant survival improvement.In terms of surgical treatment,more research has been conducted on the safety of radical laparoscopic surgery for cervical cancer compared with laparotomy surgery.Surgical modality for endometrial cancer is constantly updated and explored as well.

关 键 词：卵巢癌 宫颈癌 子宫体癌 化疗 靶向治疗 

分 类 号：R730.55[医药卫生—肿瘤]